 | HC Wainwright Reiterates "Buy" Rating for Outlook Therapeutics (NASDAQ:OTLK)
www.americanbankingnews.com - May 27 at 9:45 AM |
 | Outlook Therapeutics announces $16M private placement to advance development of ONS-5010
seekingalpha.com - May 26 at 6:35 PM |
 | Outlook Therapeutics Announces $16.0 Million Private Placement to Advance the Development of ONS-5010 / LYTENAVA™ (bevacizumab-vikg)
finance.yahoo.com - May 26 at 8:34 AM |
| FY2024 EPS Estimates for Outlook Therapeutics, Inc. Lifted by Oppenheimer (NASDAQ:OTLK)
www.americanbankingnews.com - May 21 at 11:57 AM |
| Some Analysts Just Cut Their Outlook Therapeutics, Inc. (NASDAQ:OTLK) Estimates
finance.yahoo.com - May 20 at 10:51 AM |
| Outlook Therapeutics' (OTLK) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - May 19 at 6:38 AM |
| Outlook Therapeutics' (OTLK) Buy Rating Reaffirmed at Oppenheimer
www.americanbankingnews.com - May 18 at 10:24 AM |
| Outlook Therapeutics EPS misses by $0.01
seekingalpha.com - May 15 at 8:23 AM |
| Outlook Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2020 and Provides Corporate Update
finance.yahoo.com - May 15 at 8:23 AM |
 | Global Parkinson's Disease Therapeutics Market (COVID-19 Impact Analysis) - Latest Industry Research and Future Growth Outlook
www.marketwatch.com - May 12 at 2:42 AM |
|
| Outlook Therapeutics, Inc. (NASDAQ:OTLK) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 10 at 5:01 AM |
| Outlook Therapeutics (NASDAQ:OTLK) Research Coverage Started at Brookline Capital Management
www.americanbankingnews.com - May 5 at 12:22 PM |
 | BRIEF-Outlook Therapeutics Inc - Board Increased Size Of Board From Five To Seven Members
www.reuters.com - April 21 at 9:48 PM |
 | Outlook Therapeutics to Present at the April 2020 Virtual Investor Summit
www.benzinga.com - April 15 at 9:11 AM |
 | Premature Ejaculation Therapeutics Market Outlook, 2020-2025 - High Demand for Topical Drug Therapies for PE Treatment - ResearchAndMarkets.com
www.businesswire.com - April 14 at 6:53 PM |
| Outlook Therapeutics provides clinical updates amid COVID-19
seekingalpha.com - April 14 at 1:53 PM |
| Outlook Therapeutics Provides COVID-19 Impact Update on Ongoing Clinical Trials NORSE 1 and NORSE 2
finance.yahoo.com - April 14 at 8:53 AM |
| Anemia Therapeutics Market Growth and Technology Advancement Outlook 2020 to 2029
www.marketwatch.com - April 13 at 7:50 AM |
| Investors Who Bought Outlook Therapeutics (NASDAQ:OTLK) Shares Three Years Ago Are Now Down 98%
finance.yahoo.com - March 19 at 3:12 PM |
| Outlook Therapeutics Announces LYTENAVA™ (bevacizumab-vikg), Anticipated Brand Name for ONS-5010, If Approved
finance.yahoo.com - March 5 at 8:27 AM |
 | Outlook Therapeutics, Inc. Common Stock (OTLK) SEC Filings
www.nasdaq.com - March 2 at 10:23 PM |
| Outlook Therapeutics Announces Closing of $10.2 Million Financings Priced At-The-Market
finance.yahoo.com - February 26 at 2:46 PM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Outlook Therapeutics, Inc.-OTLK
finance.yahoo.com - February 25 at 1:30 PM |
| BRIEF-Sabby Management LLC Reports 5.56% Passive Stake In Outlook Therapeutics
www.reuters.com - February 24 at 6:11 PM |
| Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
finance.yahoo.com - February 24 at 8:10 AM |
| INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Outlook Therapeutics, Inc. for Potential Securities Violations and Breach of Fiduciary Duty Claims.
finance.yahoo.com - February 18 at 5:08 PM |
| Outlook Therapeutics Provides Business Update and Reports Financial Results for the First Quarter of Fiscal Year 2020
finance.yahoo.com - February 14 at 12:27 PM |
| Outlook Therapeutics to Present at the 2020 BIO CEO & Investor Conference
finance.yahoo.com - February 4 at 8:28 AM |
|
| Outlook Therapeutics streamlines capital structure; shares down 6% premarket
seekingalpha.com - January 28 at 1:43 PM |
 | BRIEF-Outlook Therapeutics To Regain 100% Ownership Of Any Future Net Profits For Ons-5010
www.msn.com - January 28 at 8:42 AM |
| Outlook Therapeutics Announces Agreements to Streamline Capital Structure and Regain 100% Ownership of Any Future Net Profits for ONS-5010
finance.yahoo.com - January 28 at 8:42 AM |
| Global Industrial Salts Market Outlook (2018-2027) - Market Set to Reach $19.90 billion by 2027 - ResearchAndMarkets.com
www.benzinga.com - January 18 at 12:53 PM |
| Supply Chain Analytics Market Analysis, Strategic Assessment, Trend Outlook and Bussiness Opportunities 2020-2023
www.marketwatch.com - January 18 at 12:53 PM |
 | Eco Outlook epilogue: Presenters answer audience questions texted in real-time
www.bizjournals.com - January 18 at 12:53 PM |
| Philly Fed Outlook shoots higher in January
seekingalpha.com - January 18 at 12:53 PM |
| BRIEF-Outlook Therapeutics Announces Completion Of Warrant Restructuring
www.msn.com - December 26 at 9:12 AM |
| Outlook completes warrant restructuring
seekingalpha.com - December 26 at 9:12 AM |
| Outlook Therapeutics Announces Completion of Warrant Restructuring
finance.yahoo.com - December 26 at 9:12 AM |
| BRIEF-Outlook Therapeutics Announces Warrant Amendment And Restructuring Of Senior Secured Notes In Separate Transactions
www.msn.com - December 23 at 11:07 PM |
| Outlook down 63% premarket on issuing warrant amendment
seekingalpha.com - December 23 at 1:06 PM |
| Outlook Therapeutics Announces Warrant Amendment and Restructuring of Senior Secured Notes in Separate Transactions
finance.yahoo.com - December 23 at 1:06 PM |
| Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2019
finance.yahoo.com - December 19 at 8:58 AM |
| BRIEF-Outlook Therapeutics Receives FDA Agreement For Three Special Protocol Assessments For Additional Planned Clinical Trials Of ONS-5010
www.msn.com - December 3 at 7:34 PM |
| Outlook Therapeutics up 49% on advancement of ONS-5010
seekingalpha.com - December 3 at 7:34 PM |
| Outlook Therapeutics Receives FDA Agreement for Three Special Protocol Assessments for Additional Planned Clinical Trials of ONS-5010
finance.yahoo.com - December 3 at 9:33 AM |
| What Kind Of Shareholders Own Outlook Therapeutics, Inc. (NASDAQ:OTLK)?
finance.yahoo.com - November 13 at 12:12 PM |
 | Outlook Therapeutics Signs Manufacturing Supply Agreement with FUJIFILM Diosynth Biotechnologies as Part of Commercialization
www.bloomberg.com - November 9 at 11:15 PM |
| Outlook Therapeutics to Present at the 29th Annual Ladenburg Thalmann 2019 Healthcare Conference
finance.yahoo.com - September 11 at 12:29 PM |
| Outlook Therapeutics (OTLK) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow
seekingalpha.com - September 10 at 3:47 PM |
| Outlook Therapeutics to Present at the H.C. Wainwright 21st Annual Healthcare Conference
finance.yahoo.com - September 10 at 3:47 PM |
